COMMUNIQUÉS West-GlobeNewswire

Senti Bio Participates in a Virtual Investor KOL Connect Segment

21/04/2025 - 15:05

Moderated discussion with Stephen Strickland, MD, MSCI, internationally respected leukemia researcher, Director of Leukemia Research for Sarah Cannon Research Institute and Kanya Rajangam, MD, PhD, President, Head of R [...]

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

21/04/2025 - 15:15

Vancouver, Canada, April 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Hapbee Technologies Launching Highly Anticipated ‘Boosted Signals’ Feature with Upcoming New App Release

21/04/2025 - 15:15

VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF | FSE: HA1), a digital wellness technology company, today announced the upcoming rollout of a [...]

Kham's House From Grief to Grace: One Mother’s Mission to Support Young Cancer Warriors Now Celebrates Three Years of Hope

21/04/2025 - 16:00

Dallas, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Kham’s House announces its 3-year anniversary celebration, unveiling an expanded slate of services for adolescents and young adults (AYAs) facing cancer and life-altering [...]

Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

21/04/2025 - 12:00

VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve [...]

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

21/04/2025 - 12:00

Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% [...]

Alumis and ACELYRIN Announce Amended Merger Agreement

21/04/2025 - 12:30

ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company [...]

Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

21/04/2025 - 12:30

MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it [...]

Alumis and ACELYRIN Announce Amended Merger Agreement

21/04/2025 - 12:30

ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company [...]

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

21/04/2025 - 13:00

LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its [...]

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402

21/04/2025 - 13:00

Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director [...]

Apellis Announces Craig Wheeler to Join the Board of Directors

21/04/2025 - 13:00

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the [...]

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025

21/04/2025 - 13:00

PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to [...]

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402

21/04/2025 - 13:00

Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director [...]

Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines

21/04/2025 - 13:00

ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to [...]

BioCryst to Report First Quarter 2025 Financial Results on May 5

21/04/2025 - 13:00

RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025 [...]

Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting

21/04/2025 - 13:00

Company to highlight preclinical study of ARV-393, an investigational PROTAC BCL6 degrader, in combination with standard of care therapies NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN [...]

Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank

21/04/2025 - 13:01

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a [...]

Boston Hemp Launches New Line of Premium THCa Concentrates

20/04/2025 - 16:00

Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) -- Boston Hemp Inc., a leader in compliant hemp-derived cannabis, today announced the launch of its new line of premium THCa concentrates , now available to consumers [...]